Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Bakersfield › NPI 1588804777
Managed care

Independence Ipa, a Medical Group, INC. Dba Independence Medical Group

Independence Ipa, a Medical Group, INC. Dba Independence Medical Group was paid $6.77M by Medicaid between Jan 2018 and Sep 2018, across 484 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 15% of everything it billed.

33Billing provider infoINDEPENDENCE IPA, A MEDICAL GROUP, INC. DBA INDEPENDENCE MEDICAL GROUP
BAKERSFIELD, CA 93301
33aNPI1588804777assigned 02/27/2009
28Total paid$6.77M
24GClaims379,090
24DCodes billed484
24AFirst – last monthJan 2018 – Sep 2018
Compared with peers

Next to other Health Maintenance Organization providers in California

Rank by total paid#24 of 151
Median peer was paid$59K
This provider vs. median115×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018379,090$6.77M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 15% 51,211 46,814 $1.04M
S9542 Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem 10% 666 625 $698K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8.5% 21,934 20,064 $578K
J0135 Injection, adalimumab, 20 mg 4.4% 121 109 $298K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.0% 6,423 5,793 $272K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.5% 2,617 2,474 $166K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.3% 5,374 5,098 $159K
J3490 Unclassified drugs 1.8% 1,258 984 $124K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1.8% 2,939 2,917 $122K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.8% 4,974 1,772 $120K
97139 1.7% 3,843 1,000 $117K
J7050 Infusion, normal saline solution, 250 cc 1.3% 130 115 $91K
472 more codes
99243 1.3% 1,272 $89K
59425 1.3% 3,290 $85K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.2% 6,079 $85K
99204 Doctor's office visit, new patient (more involved) 1.2% 2,089 $84K
99173 1.1% 4,166 $73K
99232 Hospital visit by a doctor, follow-up day 1.1% 1,238 $72K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,393 $67K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 72 $64K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 1,053 $56K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 495 $55K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,510 $53K
77067 Screening mammography, bilateral, including computer-aided detection <1% 865 $49K
71046 Radiologic examination, chest; 2 views <1% 4,291 $49K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 772 $47K
85018 <1% 3,836 $46K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 1,849 $46K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,148 $42K
81002 <1% 3,045 $42K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 264 $41K
99051 <1% 1,559 $40K
92134 <1% 692 $39K
L3000 Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each <1% 166 $38K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 1,990 $37K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 912 $37K
99223 Prolong inpt eval add15 m <1% 473 $37K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 1,750 $34K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 37 $33K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,623 $32K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,291 $31K
92551 <1% 1,942 $31K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,285 $29K
92552 <1% 1,565 $28K
92226 <1% 815 $28K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 102 $28K
T4541 Incontinence product, disposable underpad, large, each <1% 827 $27K
81000 <1% 742 $27K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 215 $27K
71045 Radiologic examination, chest; single view <1% 2,899 $26K
92250 <1% 610 $25K
99238 Hospital discharge day management, 30 minutes or less <1% 396 $23K
99000 <1% 2,344 $23K
76641 <1% 382 $21K
81025 <1% 2,141 $21K
99244 Office or other outpatient consultation, moderate to high complexity <1% 383 $21K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 196 $20K
99222 Initial hospital care, per day, moderate complexity <1% 272 $19K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 999 $19K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 322 $19K
94760 <1% 1,657 $18K
67028 Intravitreal injection of a pharmacologic agent <1% 166 $17K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 209 $16K
59409 Vaginal delivery only (with or without episiotomy and/or forceps) <1% 39 $16K
A4351 Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each <1% 127 $16K
J9035 Injection, bevacizumab, 10 mg <1% 153 $16K
17110 <1% 203 $16K
99215 Doctor's office visit, returning patient (complex) <1% 314 $15K
95886 <1% 125 $15K
D1206 Topical application of fluoride varnish <1% 647 $15K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,691 $14K
92225 <1% 225 $13K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 502 $13K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 808 $12K
10040 <1% 149 $12K
T4535 Disposable liner/shield/guard/pad/undergarment, for incontinence, each <1% 418 $12K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 730 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 515 $11K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 16,066 $11K
81003 <1% 1,039 $10K
70450 Computed tomography, head or brain; without contrast material <1% 392 $10K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 236 $10K
T4522 Adult sized disposable incontinence product, brief/diaper, medium, each <1% 223 $10K
47562 <1% 43 $9K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 82 $9K
80305 <1% 492 $9K
94010 <1% 567 $9K
T4527 Adult sized disposable incontinence product, protective underwear/pull-on, large size, each <1% 154 $8K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 395 $8K
97161 <1% 274 $8K
76512 <1% 135 $8K
97162 <1% 346 $8K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 210 $8K
T4530 Pediatric sized disposable incontinence product, brief/diaper, large size, each <1% 98 $8K
A4267 Contraceptive supply, condom, male, each <1% 444 $8K
93000 <1% 548 $8K
68761 <1% 80 $8K
T1015 A visit at a community health center or clinic (one all-in rate) <1% 249 $8K
87806 <1% 404 $8K
80053 Comprehensive metabolic panel <1% 11,594 $8K
73562 <1% 403 $8K
88307 <1% 140 $7K
90670 <1% 667 $7K
73221 <1% 58 $7K
76830 Ultrasound, transvaginal <1% 178 $7K
90961 <1% 73 $7K
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 26 $7K
3008F <1% 416 $7K
92235 <1% 114 $7K
11721 <1% 268 $7K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 154 $7K
A5500 For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe <1% 176 $7K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 366 $6K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 132 $6K
90715 <1% 330 $6K
T4523 Adult sized disposable incontinence product, brief/diaper, large, each <1% 95 $6K
99242 <1% 177 $6K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 223 $5K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 170 $5K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 116 $5K
45384 <1% 16 $5K
77065 Tomosynthesis, mammo <1% 87 $5K
81001 <1% 8,289 $5K
72110 <1% 222 $5K
17111 <1% 55 $5K
90686 <1% 544 $5K
83655 <1% 1,138 $5K
64493 <1% 41 $5K
76642 <1% 120 $5K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 130 $5K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 94 $5K
90633 <1% 349 $5K
95115 <1% 999 $5K
77066 Tomosynthesis, mammo <1% 108 $5K
81005 <1% 293 $5K
43450 <1% 31 $5K
86580 <1% 646 $5K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 99 $5K
62323 <1% 64 $5K
11056 <1% 207 $5K
90651 <1% 442 $5K
90648 <1% 377 $5K
A5513 For diabetics only, multiple density insert, custom molded from model of patient's foot, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each <1% 116 $5K
82962 <1% 2,035 $5K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 175 $4K
T4526 Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each <1% 133 $4K
99053 <1% 152 $4K
T4528 Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each <1% 97 $4K
96103 <1% 479 $4K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 306 $4K
99239 Hospital discharge day management, more than 30 minutes <1% 137 $4K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 60 $4K
20611 <1% 101 $4K
92283 <1% 131 $4K
A7015 Aerosol mask, used with dme nebulizer <1% 262 $4K
80048 Basic metabolic panel (calcium, ionized) <1% 4,520 $4K
72082 <1% 90 $4K
90707 <1% 202 $4K
90710 <1% 243 $4K
95911 <1% 30 $4K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 168 $4K
73030 <1% 195 $3K
T1014 Telehealth transmission, per minute, professional services bill separately <1% 303 $3K
76536 <1% 81 $3K
90700 <1% 220 $3K
94726 <1% 81 $3K
Q3014 Telehealth originating site facility fee <1% 303 $3K
J7610 Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg <1% 260 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 123 $3K
83516 <1% 352 $3K
73130 <1% 200 $3K
A4927 Gloves, non-sterile, per 100 <1% 145 $3K
95012 <1% 195 $3K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 12 $3K
90723 <1% 244 $3K
92557 <1% 95 $3K
93970 <1% 24 $3K
11100 <1% 92 $3K
83735 <1% 2,389 $3K
73630 <1% 215 $3K
99091 <1% 138 $3K
64494 <1% 41 $3K
92015 Determination of refractive state <1% 75 $3K
92284 <1% 146 $3K
84484 <1% 1,638 $3K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 217 $3K
94729 <1% 81 $3K
87650 <1% 82 $3K
74018 <1% 154 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 400 $3K
A6250 Skin sealants, protectants, moisturizers, ointments, any type, any size <1% 205 $3K
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 12 $3K
85013 <1% 211 $3K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 65 $3K
90680 <1% 172 $3K
90734 <1% 220 $3K
97113 <1% 124 $3K
T4525 Adult sized disposable incontinence product, protective underwear/pull-on, small size, each <1% 65 $3K
92136 <1% 81 $2K
97001 <1% 91 $2K
99188 <1% 102 $2K
67500 <1% 13 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 435 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 638 $2K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 85 $2K
H1003 Prenatal care, at-risk enhanced service; education <1% 243 $2K
87430 <1% 82 $2K
92025 <1% 37 $2K
83690 <1% 1,869 $2K
76770 <1% 74 $2K
85610 <1% 2,156 $2K
86780 <1% 504 $2K
73610 <1% 175 $2K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 70 $2K
94060 <1% 82 $2K
72050 <1% 107 $2K
S4993 Contraceptive pills for birth control <1% 42 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,561 $2K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 126 $2K
36471 <1% 71 $2K
11101 <1% 61 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 123 $2K
99401 <1% 148 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 80 $2K
82948 <1% 991 $2K
93015 <1% 29 $2K
90696 <1% 110 $2K
83880 <1% 959 $2K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 103 $2K
92081 <1% 114 $2K
71250 <1% 18 $2K
97164 <1% 107 $2K
97014 <1% 106 $2K
97802 <1% 14 $2K
86480 <1% 1,028 $2K
83605 <1% 836 $2K
83986 <1% 49 $2K
20610 <1% 27 $2K
76942 <1% 47 $2K
96161 <1% 138 $2K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 35 $1K
64495 <1% 41 $1K
A4335 Incontinence supply; miscellaneous <1% 183 $1K
96150 <1% 87 $1K
88312 <1% 52 $1K
T4524 Adult sized disposable incontinence product, brief/diaper, extra large, each <1% 25 $1K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 115 $1K
51741 <1% 27 $1K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 14 $1K
90746 <1% 19 $1K
90716 <1% 185 $1K
A6402 Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 100 $1K
92083 <1% 30 $1K
84702 <1% 1,103 $1K
73110 <1% 130 $1K
36415 Collection of venous blood by venipuncture <1% 15,116 $1K
92567 <1% 39 $1K
87040 <1% 484 $1K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 43 $1K
90685 <1% 105 $1K
99254 <1% 31 $1K
97803 <1% 163 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,859 $1K
85730 <1% 1,471 $988.63
3074F <1% 121 $932.11
72100 <1% 45 $896.14
L3908 Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf <1% 35 $888.22
3078F <1% 120 $877.28
92020 <1% 28 $876.81
85651 <1% 1,725 $874.31
73564 <1% 15 $863.76
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 99 $848.18
84703 <1% 581 $839.18
92133 <1% 48 $836.05
A4217 Sterile water/saline, 500 ml <1% 14 $831.40
82947 <1% 343 $810.00
90713 <1% 67 $794.34
A5120 Skin barrier, wipes or swabs, each <1% 55 $748.90
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 160 $730.84
87081 <1% 597 $723.32
S9088 Services provided in an urgent care center (list in addition to code for service) <1% 22 $665.53
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 38 $654.90
69210 <1% 27 $630.00
84100 <1% 702 $612.45
93224 <1% 16 $583.67
73502 <1% 25 $580.18
76857 <1% 14 $576.50
74178 <1% 31 $575.00
99205 Prolong outpt/office vis <1% 12 $542.49
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 22 $525.00
90658 <1% 42 $518.74
20553 <1% 12 $485.34
85027 <1% 388 $446.74
99490 Ccm add 20min <1% 30 $440.67
88342 <1% 16 $438.81
88141 <1% 84 $433.79
70220 <1% 14 $430.75
95117 <1% 49 $425.25
87205 <1% 269 $409.36
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 27 $360.00
80076 <1% 1,464 $352.76
90620 <1% 12 $334.85
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 15 $321.79
11755 <1% 16 $311.64
83036 Hemoglobin; glycosylated (A1C) <1% 8,149 $308.68
99406 <1% 28 $288.63
82550 <1% 447 $267.62
71020 <1% 61 $249.61
86900 <1% 620 $244.00
84145 <1% 54 $239.27
73522 <1% 12 $234.22
92132 <1% 12 $218.80
80061 Lipid panel <1% 8,914 $213.54
86593 <1% 83 $207.00
87077 <1% 345 $184.67
86850 <1% 497 $180.47
85014 <1% 26 $180.00
J7638 Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram <1% 13 $180.00
85379 <1% 186 $178.17
86901 <1% 609 $163.90
84443 Thyroid stimulating hormone (TSH) <1% 4,090 $147.61
86592 <1% 2,200 $126.19
82803 <1% 25 $121.55
A4253 Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips <1% 161 $118.14
88720 <1% 14 $109.18
90649 <1% 12 $104.95
85007 <1% 224 $96.93
82805 <1% 115 $92.39
90698 <1% 41 $88.69
G0467 Community health center visit, returning patient <1% 12 $86.40
99201 <1% 12 $83.97
87186 <1% 377 $82.30
90688 <1% 188 $52.60
84132 <1% 49 $48.19
87420 <1% 45 $46.69
86140 <1% 1,502 $45.19
86635 <1% 573 $44.13
82150 <1% 290 $43.41
A4259 Lancets, per box of 100 <1% 58 $36.98
72072 <1% 13 $23.76
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 295 $23.50
87070 <1% 433 $15.07
84403 0% 361 $0.00
84439 0% 3,206 $0.00
86039 0% 220 $0.00
85045 0% 89 $0.00
84460 0% 214 $0.00
82570 0% 1,742 $0.00
86696 0% 503 $0.00
86735 0% 48 $0.00
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 0% 197 $0.00
86331 0% 800 $0.00
86431 0% 873 $0.00
83540 0% 657 $0.00
86694 0% 421 $0.00
84156 0% 216 $0.00
82274 0% 592 $0.00
84445 0% 13 $0.00
A7038 Filter, disposable, used with positive airway pressure device 0% 37 $0.00
86147 0% 235 $0.00
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 0% 109 $0.00
86038 0% 1,393 $0.00
86235 0% 561 $0.00
87660 0% 81 $0.00
82977 0% 230 $0.00
84450 0% 114 $0.00
86360 0% 86 $0.00
86003 0% 646 $0.00
86787 0% 219 $0.00
84520 0% 111 $0.00
82247 0% 90 $0.00
86665 0% 92 $0.00
A4232 Syringe with needle for external insulin pump, sterile, 3 cc 0% 27 $0.00
87075 0% 148 $0.00
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 0% 42 $0.00
87210 0% 210 $0.00
82785 0% 116 $0.00
98940 0% 374 $0.00
87481 0% 76 $0.00
86703 0% 706 $0.00
84550 0% 704 $0.00
83013 0% 62 $0.00
80074 0% 1,049 $0.00
87209 0% 211 $0.00
87653 0% 28 $0.00
82248 0% 629 $0.00
87338 0% 347 $0.00
87799 0% 60 $0.00
84155 0% 20 $0.00
84146 0% 227 $0.00
84481 0% 433 $0.00
83970 0% 231 $0.00
87177 0% 211 $0.00
80164 0% 107 $0.00
86200 0% 304 $0.00
82565 0% 60 $0.00
82310 0% 39 $0.00
83721 0% 219 $0.00
87512 0% 54 $0.00
84165 0% 14 $0.00
82465 0% 110 $0.00
87902 0% 27 $0.00
82627 0% 25 $0.00
80365 0% 12 $0.00
A7005 Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable 0% 55 $0.00
80361 0% 12 $0.00
86765 0% 31 $0.00
87427 0% 21 $0.00
80356 0% 12 $0.00
86708 0% 13 $0.00
83525 0% 24 $0.00
87045 0% 25 $0.00
80369 0% 12 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 0% 12 $0.00
80346 0% 12 $0.00
83992 0% 12 $0.00
90472 Immunization administration, each additional vaccine (list separately) 0% 23 $0.00
82950 0% 860 $0.00
87510 0% 146 $0.00
87340 0% 595 $0.00
86762 0% 327 $0.00
82043 0% 1,998 $0.00
86160 0% 375 $0.00
84154 0% 88 $0.00
84270 0% 215 $0.00
84153 0% 741 $0.00
86706 0% 242 $0.00
83550 0% 545 $0.00
36416 0% 92 $0.00
87480 0% 146 $0.00
86695 0% 499 $0.00
87536 0% 120 $0.00
86171 0% 637 $0.00
80081 0% 141 $0.00
84480 0% 294 $0.00
86376 0% 542 $0.00
87797 0% 65 $0.00
85652 0% 812 $0.00
88142 0% 14 $0.00
80050 General health panel 0% 4,649 $0.00
87147 0% 108 $0.00
82746 0% 554 $0.00
86225 0% 524 $0.00
83002 0% 225 $0.00
82670 0% 137 $0.00
A7013 Filter, disposable, used with aerosol compressor or ultrasonic generator 0% 36 $0.00
82952 0% 71 $0.00
86803 0% 527 $0.00
84479 0% 100 $0.00
87522 Neg quan hep c or qual rna 0% 359 $0.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 0% 3,819 $0.00
87015 0% 140 $0.00
82784 0% 213 $0.00
86704 0% 54 $0.00
86800 0% 124 $0.00
82607 0% 1,410 $0.00
83001 0% 310 $0.00
82378 0% 81 $0.00
82728 0% 555 $0.00
82105 0% 174 $0.00
84144 0% 43 $0.00
86812 0% 12 $0.00
87046 0% 154 $0.00
84436 0% 434 $0.00
80359 0% 12 $0.00
80055 0% 52 $0.00
80349 0% 26 $0.00
87088 0% 152 $0.00
80069 0% 120 $0.00
80353 0% 12 $0.00
86141 0% 12 $0.00
87486 0% 12 $0.00
L3660 Shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf 0% 12 $0.00
80156 0% 12 $0.00
87581 0% 12 $0.00
90744 0% 20 $0.00
80358 0% 12 $0.00
85008 0% 24 $0.00
86304 0% 12 $0.00
83883 0% 16 $0.00
80371 0% 12 $0.00
86255 0% 12 $0.00
A4230 Infusion set for external insulin pump, non needle cannula type 0% 12 $0.00
80352 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSVENSON, KRISTY (NETWORK DIRECTOR)